A Dose Ranging Study to Examine TDS-Testosterone 5%

NCT01894308 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
48
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Transdermal Delivery Solutions Corp

Collaborators